Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Mar-Apr;54(2):133-141.e1.
doi: 10.1016/j.jmwh.2008.09.010.

Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet

Suellen Miller  1 , Carrie Tudor, Vanessa Thorsten, Nyima, Kalyang, Sonam, Lhakpen, Droyoung, Karma Quzong, Tsering Dekyi, Ty Hartwell, Linda L Wright, Michael W Varner
Affiliations
Randomized Controlled Trial

Randomized double masked trial of Zhi Byed 11, a Tibetan traditional medicine, versus misoprostol to prevent postpartum hemorrhage in Lhasa, Tibet

Suellen Miller et al. J Midwifery Womens Health. 2009 Mar-Apr.

Abstract

The objective of this study was to compare a Tibetan traditional medicine (the uterotonic Zhi Byed 11 [ZB11]) to oral misoprostol for prophylaxis of postpartum hemorrhage (PPH). We conducted a double-blind randomized controlled trial at three hospitals in Lhasa, Tibet, People's Republic of China. Women (N = 967) were randomized to either ZB11 or misoprostol groups. Postpartum blood loss was measured in a calibrated blood collection drape. The primary combined outcome was incidence of PPH, defined as measured blood loss (MBL) > or = 500 mL, administration of open label uterotonics, or maternal death. We found that the rate of the combined outcome was lower among the misoprostol group (16.1% versus 21.8% for ZB11; P = .02). Frequency of PPH was lower with misoprostol (12.4% versus 17.4%; P = .02). There were no significant differences in MBL > 1000 mL or mean or median MBL. Fever was significantly more common in the misoprostol group (P = .03). The rate of combined outcome was significantly lower among women receiving misoprostol. However, other indices of obstetric hemorrhage were not significantly different.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Zhi Byed 11 (ZB11) ingredients.
Figure 2
Figure 2
Trial profile.
See this image and copyright information in PMC

References

    1. World Health Organization. The world health report 2005: Make every mother and child count. Geneva: World Health Organization; 2005.
    1. Liang J, Wang YP, Wu YQ, Zhou GX, Zhu J, Dai L, et al. Maternal mortality in rural areas of China. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004;35:258–60. - PubMed
    1. Tshomo M. Knowledge of pregnancy and delivery and obstetrical diseases and treatments from a Tibetan medical perspective [master’s thesis] Lhasa, Tibet: Tibetan Medical College; 2004.
    1. Duke J. Phytochemical and ethnobotanical databases. [Accessed August 1, 2007]. Available from: www.ars-grin.gov/duke/
    1. University of Utah Center for Human Toxicology. Solid material sample; analysis consultant case CC-20–03. Salt Lake City, UT: Jul 31, 2003.

Publication types